Delaware Clinical and Translational Research ACCEL Program (Admin Core)

特拉华州临床和转化研究 ACCEL 计划(管理核心)

基本信息

  • 批准号:
    10892513
  • 负责人:
  • 金额:
    $ 30.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-25 至 2028-06-30
  • 项目状态:
    未结题

项目摘要

ABSTRACT- ADMINISTRATIVE CORE The ACCEL CTR Program has successfully met the expectations of this award mechanism by expanding the capacity for clinical and translational research in Delaware and enhancing our investigators’ ability to successfully compete for extramural funding in this arena. The success of ACCEL is anchored in the complementary strengths of the partnership network been built over the past nine years. Our current network consists of the University of Delaware (lead institution), Christiana Care Health System, Nemours Children’s Health and Delaware State University—an American, historically Black, public university. To date, ACCEL has established an exceedingly strong network and infrastructure for clinical and translational research within Delaware; and, we are now poised and ready to continue our growth trajectory by building a deeper focus on health equity into our clinical and translational research infrastructure. The planned components of the ACCEL Program include the Administrative Core and five other required Cores, including: the Professional Development Core; the Biostatistics, Epidemiology, & Research Design Core; the Community Engagement & Outreach Core; the Pilot Projects Program, and the Tracking and Evaluation Core. The overall goal of the Administrative Core is to improve the efficiency, productivity and impact of the five other Cores so that we are able to successfully meet our common mission of building clinical and translational research infrastructure that will be sustainable and ultimately improve the health of Delawareans. We believe that we have a very effective administrative structure that does not require substantial change. But, in this renewal application, we propose an exciting new addition to the Administrative Core—a Health Equity Navigator, who will work closely with all Core leaders to weave the thread of health equity throughout all aspects of the ACCEL program. The Health Equity Navigator will keep the network focused on health equity as we strengthen our clinical and translational research infrastructure. The Specific Aims of the Administrative Core are to continue to: (1) Provide a flexible and efficient administrative and governance structure that enhances the DE-CTR ACCEL Program’s ability to grow and sustain clinical and translational research programs that address the most important health care needs of Delawareans and all Americans; (2) Manage the financial and business operations of the DE-CTR ACCEL Program to ensure operational efficiency, sound fiscal health of the organization and compliance with all federal, state and local regulations; (3) Enhance and promote data-informed decision-making, communication and collaboration across all ACCEL components, participating institutions and other IDeA programs; and (4) Facilitate the implementation of strategic, high- value initiatives that will enhance the ACCEL Program’s ability to address health inequities and improve infrastructure for clinical and translational research within the state of Delaware.
摘要-行政核心 ACCEL CTR计划成功地满足了这一奖励机制的期望, 在特拉华州进行临床和转化研究的能力,并提高我们的研究人员的能力, 在这个竞技场里成功地争取到校外资助。ACCEL的成功在于 过去九年来建立的伙伴关系网络优势互补。我们目前 该网络由特拉华州大学(牵头机构),克里斯蒂安娜护理卫生系统, 内穆尔儿童健康和特拉华州州立大学-一个美国,历史上的黑人,公立 大学到目前为止,ACCEL已经建立了一个非常强大的网络和基础设施, 和转化研究在特拉华州;而且,我们现在已经准备好,并准备继续我们的增长 通过在我们的临床和转化研究中更深入地关注健康公平, 基础设施演进ACCEL计划的计划组成部分包括行政核心和五个 其他所需的核心,包括:专业发展核心;生物统计学,流行病学,和 研究设计核心;社区参与和推广核心;试点项目计划,以及 跟踪和评估核心。行政核心的总体目标是改善 效率,生产力和其他五个核心的影响,使我们能够成功地满足我们的 建立可持续的临床和转化研究基础设施的共同使命, 最终改善特拉华人的健康状况。我们相信,我们有一个非常有效的行政 不需要进行实质性改变的结构。但是,在这一更新申请中,我们提出了一个 令人兴奋的新增加的行政核心-健康公平导航,谁将密切合作,所有 核心领导人在ACCEL计划的各个方面编织健康公平的线索。的 健康公平导航将保持网络重点放在健康公平,因为我们加强了我们的临床和 翻译研究基础设施。行政核心的具体目标是继续:(1) 提供一个灵活和有效的行政和治理结构,以加强环境、技术和资源管理 ACCEL计划发展和维持临床和转化研究计划的能力, 特拉华人和所有美国人最重要的医疗保健需求;(2)管理财务和 业务运营的DE-CTR ACCEL计划,以确保运营效率,健全的财政健康 (3)遵守所有联邦、州和地方法规;(4)加强和促进 数据知情决策,所有ACCEL组件之间的沟通和协作, 参与机构和其他IDEA计划;以及(4)促进战略,高, 重视将提高ACCEL计划解决卫生不公平问题和改善 在特拉华州的临床和转化研究的基础设施。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gregory E Hicks其他文献

Gregory E Hicks的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gregory E Hicks', 18)}}的其他基金

Turning the TiDe: Training Diverse Clinician Scientists in Rehabilitation Research
扭转局势:培训康复研究领域的多元化临床科学家
  • 批准号:
    10686197
  • 财政年份:
    2022
  • 资助金额:
    $ 30.16万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10437677
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10885455
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10841849
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10721011
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program-Admin Core
特拉华州临床和转化研究 ACCEL 计划-管理核心
  • 批准号:
    10437678
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10372245
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:
Resveratrol for the prevention of bone loss in postmenopausal women with osteopenia
白藜芦醇预防绝经后骨质减少女性骨质流失
  • 批准号:
    10728055
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program (Admin Core)
特拉华州临床和转化研究 ACCEL 计划(管理核心)
  • 批准号:
    10721012
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10223322
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了